SUMMARY Measurements of cerebrospinal fluid (CSF) and plasma amino acid concentrations have been made in 12 patients with the Guillain-Barre syndrome. The CSF protein concentration was normal in seven specimens and raised in 13. Abnormalities of the CSF amino acid profile were found in all specimens but were more marked in those with a raised CSF protein concentration. The possible causes and diagnostic significance of these changes are discussed.
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The concentration of amino acids in the cerebrospinal fluid (CSF) of normal individuals is much lower than that of the plasma.' Small disturbances of the CSF amino acid profile have been described in various neurological diseases such as Parkinsonism,2 epilepsy,3 and Huntington's chorea;4 the most marked abnormalities have been found in patients with purulent meningitis where the changes were thought largely to result from a breakdown of the blood-CSF barrier. 5 The Guillain-Barre syndrome is associated with a rise in the CSF protein concentration at some stage of the disease and it is claimed that this largely results from a breakdown of the blood-CSF barrier."-11 The present study was therefore designed to see if there was a change in the CSF amino acid profile in this disorder accompanying the rise in protein concentration.
Patients studied
Twelve patients were studied. Details of age, sex and the CSF protein concentrations and white cell counts are shown in table 1. Six of the patients were male and six female. Their mean age was 403 years (range 11-68 years). All conformed to the diagnostic criteria 86 for the Guillain-Barre syndrome as proposed by the American National Institute of Neurological and Communicative Disorders and Stroke. 12 Simultaneous specimens of lumbar CSF and venous blood were collected after an overnight fast of 12-18 hours. Five patients had their CSF and plasma amino acid concentrations measured on one occasion only; six on two occasions and in one patient they were measured on three occasions. The specimens were obtained between the 5th and 63rd days after the development of neurological symptoms. Although all but one patient (EP) were treated with either ACTH or oral steroids samples of CSF and blood were obtained from six patients before treatment started. Analysis of specimens The specimens of CSF and venous blood were centrifuged (4000 g, 10 min, 4C), deproteinised and stored at -20'C. They were analysed for their free amino acid concentration as described previously.' Glutamine and glutamic acid concentrations were measured on an aliquot of the same specimen by a double enzymatic procedure.13 A sample of each CSF specimen was examined by microscopy and cultured for bacteria and viruses. Measurements of protein and sugar concentrations and a differential white cell count were carried out using standard laboratory procedures. Serological tests for syphilis were carried out on each specimen and all were negative. Each patient had virus antibody titres in the serum measured on two occasions and no abnormally raised values were found. One patient (CW) had a positive Paul Bunnel test together with atypical lymphocytes in the blood confirming a diagnosis of infectious mononucleosis. 
Discussion
In the present study we have shown a disturbance in CSF amino acid composition in patients with the Guillain-Barr6 syndrome which involved an alteration in concentration of 15 amino acids. These abnormalities were most marked when the CSF protein concentration was raised.
It seems most probable that some of these abnormalities result from a breakdown of the blood-CSF barrier to amino acids. Several observations would support this view. Firstly, there is evidence that the rise in CSF protein concentration in the Guillain-Barr6 syndrome results from a breakdown of the blood-CSF barrier;7"11 in the present study the concentration of 12 amino acids was raised in patients with an elevated CSF protein concentration while only six of these were raised when the protein concentration was normal. Secondly, previous studies from this department and elsewhere done on patients with meningitis have shown that the large increase in CSF protein and amino acid concentrations are most likely to result from a breakdown of the blood-CSF barrier.) 14 In the Guillain-Barre syndrome it is possible that the breakdown of the barrier might occur at the nerve roots where there is evidence that a protein-rich oedema fluid collects'5 and protein leakage occurs.¢ Alternatively, an inflammatory reaction might occur in the choroid plexus and disturb the transport processes at this site.1 [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Evidence for this latter mechanism is based on the morphological, molecular and functional similarities between the choroid plexus and the renal glomerulus2' and the presence of immunological cross-reactivity between these tissues. 22 Since glomerulonephritis has been shown to occur commonly in patients with the Guillain-Barre syndrome26 and since there has been histological confirmation of immune-complex nephritis in patients with this syndrome27 28 it would seem reasonable to infer that immunological damage might also occur in the choroid plexus. This might be initiated by immune complexes containing circulating antibodies to peripheral nerve tissue which are known to occur in this syndrome .29 In agreement with our earlier studies on normal and patients with meningitis5 it is unlikely that changes in plasma amino acid concentrations are an important factor in producing the changes in the CSF since there was a simultaneous increase in CSF and plasma concentrations of only three amino acids. It also seems unlikely that the CSF amino acid changes result from the breakdown of myelin protein during demyelination of thc nerve roots which occurs in the Guillain-Barr6 syndrome30 since two of the amino acids present in high concentration in mammalian myelin protein (glutamic acid and serine),5' were found in low concentration in the CSF.
Irrespective of the processes involved, disturbance of CSF amino acid profile might be of use in helping to confirm the diagnosis of the Guillain-Barr6 syndrome. At present the CSF protein concentration is routinely measured but is not always found to be raised.12 In this s udy we have found disturbances of the normal CSF amino acid composition even in the presence of a normal protein concentration.
